ARTICLE | Clinical News
Pomalyst pomalidomide regulatory update
April 13, 2015 7:00 AM UTC
Japan approved Pomalyst pomalidomide from Celgene to treat relapsed or refractory multiple myeloma (MM) in patients previously treated with Revlimid lenalidomide and Velcade bortezomib. Pomalidomide...